Prelude Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,796
| Closed | -$202K | – | 1577 |
|
|
2021
Q4 | $202K | Buy |
+10,796
| New | +$202K | 0.01% | 1226 |
|
|
2021
Q2 | – | Sell |
-8,871
| Closed | -$210K | – | 1391 |
|
|
2021
Q1 | $210K | Sell |
8,871
-4,973
| -36% | -$118K | 0.01% | 917 |
|
|
2020
Q4 | $277K | Buy |
+13,844
| New | +$277K | 0.01% | 543 |
|
|
2020
Q3 | – | Sell |
-34,889
| Closed | -$611K | – | 1446 |
|
|
2020
Q2 | $611K | Buy |
34,889
+554
| +2% | +$9.7K | 0.03% | 246 |
|
|
2020
Q1 | $561K | Buy |
+34,335
| New | +$561K | 0.04% | 164 |
|
|
2019
Q3 | – | Sell |
-2,500
| Closed | -$33K | – | 1246 |
|
|
2019
Q2 | $33K | Sell |
2,500
-2,700
| -52% | -$35.6K | ﹤0.01% | 860 |
|
|
2019
Q1 | $79K | Buy |
+5,200
| New | +$79K | ﹤0.01% | 686 |
|